Wellington Management

AssetWatch specializes in proactive and predictive maintenance solutions aimed at preventing unplanned downtime for global manufacturers. The company offers an extensive remote condition monitoring service that integrates wireless sensors and communication hubs with sophisticated software. These wireless vibration and temperature sensors gather critical machine health data, which is analyzed using machine learning algorithms and the expertise of condition monitoring engineers. This analysis provides actionable insights that go beyond simple pass/fail assessments, enabling manufacturers to transition from a reactive to a proactive maintenance culture. By delivering prescriptive recommendations, AssetWatch supports manufacturers in optimizing their maintenance processes and enhancing operational reliability.

Maza is a mobile application that operates as a digital bank, providing a range of modern banking services. The platform offers users access to savings accounts, NFC-enabled prepaid cards for both online and offline transactions, as well as bill payment and money transfer services. By focusing on user-friendly features, Maza aims to deliver a hassle-free banking experience that encourages financial savings and efficient management of personal finances.

Atsena Therapeutics is a clinical-stage gene therapy company focused on developing treatments for inherited retinal diseases that can lead to blindness. Their clinical pipeline includes therapies for conditions such as X-linked retinoschisis and GUCY2D-associated Leber congenital amaurosis. Atsena employs an adeno-associated virus (AAV) technology platform, including a novel spreading capsid, to specifically target these retinal disorders. The company aims to prevent vision loss caused by genetic mutations through innovative ocular gene therapy solutions. With a commitment to advancing treatments for some of the most challenging forms of inherited retinal disease, Atsena Therapeutics seeks to improve the lives of patients affected by these conditions.

Lumafield specializes in industrial computed tomography (CT) solutions, providing advanced non-destructive testing and inspection tools for engineers. The company's flagship product, the Neptune X-ray CT scanner, offers detailed imaging that allows engineers to analyze internal structures and identify defects in various materials. Complementing this hardware is the Voyager software platform, which facilitates cloud-based, AI-powered analysis, enabling automated inspections and collaborative efforts among teams. Additionally, Lumafield's Triton system is designed for high-speed scanning, catering to the needs of high-volume manufacturing environments. The company serves diverse industries, including aerospace, automotive, electronics, and medical devices, aiming to enhance product quality and reliability throughout the product development process.

Just Salad is a fast-casual restaurant chain that focuses on providing healthy and affordable meals, including salads, wraps, smoothies, and soups. The company emphasizes sustainability through various initiatives, such as its Reusable Bowl Program, which encourages customers to bring their own bowls for discounts, thereby reducing single-use packaging waste. Additionally, Just Salad was the first restaurant chain in the United States to implement a carbon-labeled menu, which highlights the environmental impact of each meal. The chain utilizes compostable packaging and recycling programs to further minimize waste, aligning its operations with a commitment to health and sustainability while offering fresh ingredients and nutritious options at accessible prices.

MedinCell S.A. is a pharmaceutical company based in Jacou, France, that specializes in developing long-acting injectable drug delivery systems using its proprietary BEPO technology. This innovative approach employs biocompatible materials to create formulations that allow for controlled and sustained release of active pharmaceutical ingredients. The company is advancing several product candidates, including mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, MedinCell is exploring various formulations in research, such as mdc-WWM for contraception and mdc-ANG for central nervous system disorders. The firm focuses on optimizing the efficiency and accessibility of medical treatments across different therapeutic areas through its ongoing research and development efforts.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.

Swanston Labs builds data-driven solutions aimed at disrupting the convergence of media, entertainment, technology, and commerce. The company focuses on leveraging innovative technologies to address the $7 trillion global leisure spending market. Swanston Labs operates under the Swanston Organization, which also includes Swanston Family Ventures and Swanston Philanthropy, collectively advancing the mission of innovation and inclusion.

Helicore Biopharma is a biopharmaceutical company dedicated to developing innovative treatments for obesity and related metabolic disorders. Its portfolio includes novel therapeutics based on glucose-dependent insulinotropic peptide (GIP) antagonism and monoclonal antibodies that bind circulating GIP ligands, forming a modular platform for anti-obesity medicines. The company aims to help patients with obesity and related conditions achieve significant weight loss.

Genius Sports Group Limited, founded in 2000 and headquartered in London, is a leading provider of technology-driven solutions in the sports data and betting industries. Through its subsidiaries, the company offers a range of services, including sports data software for leagues and governing bodies, live betting products, and personalized marketing campaigns for the sports betting sector. Genius Sports has established itself as a trusted partner to numerous international sports organizations, including major federations and professional leagues. Its commitment to the integrity and commercialization of sports data is central to its operations, emphasizing collaboration between sports organizations and data users to ensure both protection and opportunity maximization. The company's offerings are categorized into three main areas: Sports Technology and Services, Betting Technology, and Media Technology, all supported by a robust proprietary data infrastructure. Genius Sports primarily generates revenue from its Betting Technology division and has a significant presence in the European market.

Thoras.ai is an AI cloud management platform..It helps to detection, monitor performance, and manage costs.

Saluda Medical, established in 2010, is a global medical device company specializing in neuromodulation technologies. Headquartered in Australia with offices in the US and UK, the company develops and commercializes innovative, closed-loop spinal cord stimulation systems. These systems measure and adapt to the spinal cord's response to stimulation, optimizing therapy within each patient's unique therapeutic window. Saluda's primary focus is treating chronic neuropathic pain, with its devices designed to automatically adjust electrical stimulation based on real-time neurophysiological feedback, tailoring treatment to individual patient needs.

SiteOne Therapeutics is a San Francisco-based company focused on developing innovative therapeutics and diagnostics for the treatment of acute and chronic pain. The company aims to address the limitations of existing pain management therapies, such as non-steroidal anti-inflammatory drugs (NSAIDs) and opioids, by creating safer and more effective alternatives. Their lead candidates are highly selective inhibitors of the voltage-gated sodium ion channel Naᵥ1.7, which is crucial in the generation and conduction of pain signals. By targeting this channel, SiteOne Therapeutics seeks to provide healthcare professionals with advanced treatment options for neuropathic pain, ultimately improving patient outcomes and efficiency in pain management.

Databricks Inc. is a technology company that provides a unified data analytics cloud platform designed to facilitate data engineering and collaborative data science. The company offers a comprehensive suite of tools, including a just-in-time data platform that simplifies data integration, real-time experimentation, and deployment of production applications for developers and data scientists. Key products include Databricks Delta, which combines the capabilities of data warehouses with low-latency streaming, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, manufacturing, and telecommunications, and has established strategic partnerships with various organizations to enhance its offerings. Founded in 2013, Databricks is headquartered in San Francisco, California, with additional offices in London, Amsterdam, and Bengaluru.

Current is a consumer fintech banking platform dedicated to enhancing financial access for everyday Americans. The company focuses on developing integrated solutions that address the barriers preventing individuals from achieving their financial goals. By simplifying banking processes and providing user-friendly tools, Current aims to empower users to build a secure financial future. With backing from prominent investors, Current continues to innovate in the financial technology space, striving to meet the diverse needs of its customer base through modern banking solutions.

Archer is an aerospace company based in the San Francisco Bay Area, dedicated to advancing sustainable air mobility. The company specializes in designing, manufacturing, and operating all-electric vertical takeoff and landing aircraft aimed at enhancing urban mobility. Archer's flagship aircraft is designed to carry four passengers for up to 60 miles at speeds of up to 150 mph, with minimal noise production.

nChroma Bio is a biotechnology company specializing in targeted genetic medicine. It operates an integrated product engine for safe, accurate, and targeted in vivo administration, aiming to overcome limitations of current genetic medicine techniques. The company focuses on liver-targeted therapies, initially for chronic hepatitis B and D, leveraging epigenetics to enable precise and specific gene regulation. This approach allows for therapies with programmable tissue specificity, potentially offering durable and targeted cures for the liver and other organs.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Olema Oncology is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for estrogen receptor (ER) positive breast cancer. The company specializes in the discovery and commercialization of targeted treatments aimed at improving outcomes for women with cancer. Olema utilizes its extensive knowledge of endocrine-driven cancers and the molecular mechanisms of the ER to create drug candidates that are designed to outperform existing therapies. Currently, the company's product pipeline includes OP-1250 and OP-3136, both of which have completed discovery and preclinical studies. Olema's mission is to transform the standard of care for both pre- and post-menopausal women by providing more effective and convenient treatment options.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.

Beta Bionics is a biotechnology company focused on developing an integrated bionic pancreas system known as the iLet. This innovative device aims to alleviate the challenges and costs associated with diabetes care by providing a dual-chamber infusion pump that delivers insulin and glucagon with precision. The iLet autonomously calculates and administers the necessary doses, enabling patients to effectively manage their blood sugar levels. The system has received breakthrough designation for all its configurations, including insulin-only, glucagon-only, and bihormonal options, and is compatible with Zealand Pharma’s dasiglucagon, a glucagon analogue known for its stability in a ready-to-use aqueous solution. Through this technology, Beta Bionics seeks to improve the quality of life for individuals living with diabetes.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines targeting verified biology to improve care for patients with solid tumors.

Crisp, Inc. is a technology company established in 2018 and headquartered in Brooklyn, New York, that specializes in demand forecasting software tailored for the food industry. The company offers a data platform that connects consumer packaged goods (CPG) brands with real-time point-of-sale and inventory data from over 40 retailers and distributors. By leveraging advanced analytics and business intelligence tools, Crisp provides actionable insights through interactive dashboards, enabling nearly 6,000 CPGs to optimize sales and supply chain operations. The platform's primary aim is to enhance efficiency within the food supply chain, helping retailers and suppliers manage inventory effectively while reducing waste.

Trace Machina is a technology company that develops and maintains open-source simulation infrastructure. It focuses on advanced technologies such as AI, robotics, and autonomous mobility to reduce simulation costs for safety-critical systems. The company's work enables builders to create futuristic technologies using existing infrastructure and tools.

Mindset specializes in providing assistance to individuals with mental illnesses and their caregivers in navigating the application process for Social Security Disability benefits. The company offers comprehensive guidance to help clients access Social Security Disability Insurance, which can cover living expenses and medical bills. Additionally, Mindset provides around-the-clock monitoring to support patients with physical impairments in securing additional benefits, thereby facilitating a better quality of life. Through its services, Mindset aims to simplify the complex process of obtaining disability benefits, ensuring that clients receive the financial support they need.

Abnormal Security Corporation specializes in cloud-based email security solutions for Microsoft Office 365 and G Suite, aiming to protect organizations from targeted email attacks. Founded in 2018 and based in San Francisco, the company employs a data science approach to enhance its email protection capabilities. Its platform offers a range of services, including inbound email protection, detection of email account compromises, and responses to various threats. Abnormal Security addresses issues such as credential phishing, internal phishing, impersonation of employees and executives, vendor account compromise, as well as invoice and payment fraud. The company serves diverse sectors, including financial services, healthcare, and utilities, providing comprehensive solutions to safeguard against email-related risks that can lead to significant financial and reputational damage.

MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.

Day One Biopharmaceuticals is a clinical-stage biotechnology company that specializes in developing targeted cancer therapies for patients of all ages, with a particular focus on pediatric patients. Recognizing the advancements in cancer research, the company aims to create treatments that can benefit both children and adults diagnosed with genetically defined cancers. Day One Biopharmaceuticals prioritizes the rapid development of therapies to meet the urgent needs of families facing cancer diagnoses. Their lead product candidate, DAY101, is an oral, highly-selective pan-RAF kinase inhibitor designed to penetrate the brain, addressing a significant treatment gap in pediatric oncology. By licensing and acquiring promising products from research institutions and other companies, Day One Biopharmaceuticals strives to bring effective medicines to market for those impacted by cancer.

Scorpion Therapeutics, Inc. is a biotechnology company based in Boston, Massachusetts, focused on developing next-generation precision oncology technologies for cancer treatment. Founded in 2020, the company specializes in creating targeted small-molecule drugs that interact with validated cancer targets. Its research encompasses therapies aimed at known oncogenes, previously undruggable cancer targets, and novel targets. By integrating technologies across target discovery, medicinal chemistry, and translational medicine, Scorpion Therapeutics aims to advance a comprehensive pipeline of optimized compounds. The company's goal is to expand the reach of precision medicine, enabling healthcare professionals to offer innovative treatments to a broader range of cancer patients.

Element Biosciences, Inc., established in 2017 and headquartered in San Diego, California, specializes in developing innovative genetic analysis tools for research and diagnostic markets. The company's core business revolves around its disruptive DNA sequencing technology, which encompasses surface chemistry, sequencing chemistry, detection methods, and data analysis. Element Biosciences aims to enhance accessibility to next-generation sequencing by offering a modular, high-performing platform that delivers high-quality data and workflow flexibility, thereby reducing run and capital costs.

TS Conductor focuses on high-performance conductors designed for modern power grids, utilizing innovative transmission technology that features a carbon-fiber-composite core instead of traditional steel. This advancement results in conductors that are both lighter and stronger, enabling them to carry greater electrical currents with reduced energy loss and enhanced efficiency. The company manufactures covered conductors with an aluminum encapsulation, which safeguards the composite core from damage and corrosion. This design not only increases the capacity and reliability of electricity transmission and distribution but also promotes sustainability within the energy sector in a cost-effective manner.

Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.

GrayMatter Robotics specializes in addressing complex surface treatment and finishing challenges encountered by manufacturers with high-mix, high-variability production needs. The company develops advanced robotics equipped with proprietary artificial intelligence, which are integrated into smart robotic cells. These systems are designed to assist human operators in performing tedious and ergonomically challenging tasks, thereby enhancing operational efficiency and productivity. By leveraging its innovative technologies, GrayMatter Robotics aims to streamline manufacturing processes, making them more effective and user-friendly for clients in various industries.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative treatments for severe hematologic disorders. Founded in 2017, the company specializes in human genetics-based therapeutics that aim to improve red blood cell production in patients suffering from various hematologic diseases. Disc Medicine's pipeline includes therapeutic candidates targeting critical pathways involved in red blood cell biology, such as heme biosynthesis and iron homeostasis. Notable programs include bitopertin, which is being developed for conditions like erythropoietic porphyrias and Diamond-Blackfan anemia. Through its research and development efforts, Disc Medicine seeks to transform the lives of patients affected by these challenging disorders.

Cargo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation CAR T-cell therapies aimed at overcoming cancer treatment resistance and improving patient access to potentially curative options. The company aims to enhance treatment outcomes by addressing the limitations of existing therapies, which currently provide curative benefits to less than half of cancer patients. Its lead program, CRG-022, is a novel CAR T-cell product candidate that targets CD22, a tumor antigen prevalent in many B-cell malignancies. By tackling issues such as limited durability, safety concerns, and supply chain obstacles, Cargo Therapeutics is committed to advancing innovative solutions that make effective cancer treatments more accessible to patients.

Scale AI, Inc. is a data platform provider specializing in training and validation data for artificial intelligence applications. Founded in 2016 and headquartered in San Francisco, the company offers various annotation tools including Scale Image for image data, Scale Video for video data, Scale Text for text data, and Scale Document for intelligent document processing. Its advanced platform also includes Scale Nucleus, which helps manage user data. Scale AI's products support a wide range of sectors, such as autonomous vehicles, retail, conversational AI, and robotics, facilitating tasks like content moderation and transcription. By focusing on providing high-quality labeled data, Scale AI enables organizations to accelerate the development of AI technologies, allowing clients to concentrate on building innovative models rather than data preparation.

Bluejay Therapeutics is a biopharmaceutical company dedicated to developing cures for infectious diseases, with a primary focus on chronic Hepatitis B. This condition poses a significant global health challenge, and the company aims to address the urgent need for effective treatments. Bluejay is advancing two innovative therapeutic approaches: best-in-class fully human IgG1 anti-HBs monoclonal antibodies and first-in-class oral small molecule inhibitors targeting HBsAg. These strategies are designed to reduce hepatitis B surface antigen levels and restore adaptive immunity, potentially leading to a functional cure for patients. Additionally, the company’s research encompasses therapeutic options for chronic Hepatitis D, further solidifying its commitment to improving immunity and recovery for individuals affected by serious viral and liver diseases.

Zenas BioPharma is a clinical-stage biopharmaceutical company based in Florida, dedicated to developing immune-based therapies for patients. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody that targets both CD19 and FcγRIIb, which are found on B cells. This innovative approach aims to inhibit the activity of B cells involved in various autoimmune diseases while preserving their overall population, thus offering a potential therapeutic advantage over traditional treatments that deplete these cells.

Wiz, Inc. is a cybersecurity company founded in 2020, with headquarters in Palo Alto, California, and an additional office in Tel Aviv, Israel. The company specializes in cloud security, providing enterprises with a platform that enables them to identify security issues within their public cloud infrastructure. Wiz's innovative solution offers a comprehensive, cloud-native visibility tool that analyzes the entire cloud environment, delivering a 360-degree view of security risks across various platforms, including clouds, containers, and workloads. The platform utilizes actionable, graph-based analysis to facilitate in-depth risk assessment and root cause analysis without the need for agents, allowing organizations to enhance their security posture effectively.

BridgeBio Oncology Therapeutics is a biopharmaceutical company specializing in the development of precision oncology therapeutics. It focuses on targeting RAS-dependent cancers, leveraging a profound understanding of RAS signaling biology to create drugs that selectively inhibit RAS-driven PI3K activation and a wide spectrum of KRAS mutants. The company aims to provide patients with tailored treatments that address both active and inactive cancer-driving states.

Finvero is a credit marketplace established in January 2021 in Mexico City, Distrito Federal. The company provides a platform that allows merchants to register their businesses and access personalized financing services. By connecting businesses with a pool of lenders, Finvero enables merchants to offer credit options to their customers, thereby increasing average ticket sales. The platform simplifies the management of various credit products, assisting both physical and online stores in enhancing their operations and facilitating daily transactions for their clientele.

Asher Biotherapeutics, Inc. is a biotechnology company based in South San Francisco, California, founded in 2019. The company specializes in the development of immunotherapy drugs aimed at effectively treating cancer. Its innovative therapies are designed to enhance the immune system's ability to target and eliminate cancer cells while minimizing side effects. This focus allows healthcare providers to deliver effective treatments to patients in a shorter timeframe, aiming to improve overall outcomes in cancer care.

Obsidian Therapeutics develops innovative cell and gene therapies aimed at enhancing adoptive immunotherapy for cancer patients. Founded in 2015 and based in Cambridge, Massachusetts, the company focuses on creating next-generation therapies that utilize pharmacologic operating systems to provide precise control over protein activity within cells. This technology allows for the development of adoptive cell therapies with advanced functionalities that can be managed by physicians using simple, safe, and orally active medications. By offering improved control over treatment, Obsidian Therapeutics aims to provide better outcomes for patients compared to existing cell therapy options.

Avidity Biosciences, Inc. is a biotechnology company focused on developing oligonucleotide-based therapies known as antibody oligonucleotide conjugates (AOCs). These innovative therapies aim to address the limitations of traditional oligonucleotide treatments by combining the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide therapies. This approach allows Avidity to target previously undruggable tissue and cell types, thereby addressing the underlying genetic drivers of various diseases. The company's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, a rare muscle disease. Additionally, Avidity is advancing multiple programs aimed at treating muscle-related conditions such as muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe disease. Founded in 2012 and based in La Jolla, California, Avidity is also exploring therapeutic applications in immune and other cell types.

AssetWatch specializes in proactive and predictive maintenance solutions aimed at preventing unplanned downtime for global manufacturers. The company offers an extensive remote condition monitoring service that integrates wireless sensors and communication hubs with sophisticated software. These wireless vibration and temperature sensors gather critical machine health data, which is analyzed using machine learning algorithms and the expertise of condition monitoring engineers. This analysis provides actionable insights that go beyond simple pass/fail assessments, enabling manufacturers to transition from a reactive to a proactive maintenance culture. By delivering prescriptive recommendations, AssetWatch supports manufacturers in optimizing their maintenance processes and enhancing operational reliability.

Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

Maza is a mobile application that operates as a digital bank, providing a range of modern banking services. The platform offers users access to savings accounts, NFC-enabled prepaid cards for both online and offline transactions, as well as bill payment and money transfer services. By focusing on user-friendly features, Maza aims to deliver a hassle-free banking experience that encourages financial savings and efficient management of personal finances.

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.

Avalyn Pharma, Inc. is a biopharmaceutical company focused on developing therapies for idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company is advancing inhaled formulations of pirfenidone, specifically AP01, which aims to enhance drug delivery to the lungs while potentially reducing side effects associated with oral treatments. This innovative approach seeks to improve the care and outcomes for patients suffering from these conditions. Established in 2011, Avalyn Pharma operates from its headquarters in Seattle, Washington, and maintains an additional office in San Diego, California. The company was previously known as Genoa Pharmaceuticals, Inc. before rebranding in July 2017.

Fore Biotherapeutics is a clinical-stage biotechnology company focused on developing precision oncology treatments tailored to patients with specific genetic mutations. By utilizing functional genomics, the company aims to create a pipeline of therapies that address unmet needs in cancer care. Fore Biotherapeutics conducts research to replicate naturally occurring mutations in vitro, allowing for the assessment of their impact on cellular signaling pathways and responses to various compounds. This approach not only facilitates the identification of novel target mutations but also helps biopharma companies broaden the patient subgroups that may benefit from existing cancer therapies.

Trove is a technology company based in Ann Arbor, Michigan, and Brisbane, California. It operates two distinct businesses: a SaaS platform that uses AI to analyze teams' email connections, providing insights to help build and leverage professional networks; and a leading platform for branded resale and trade-in, enabling brands to launch, manage, and scale their resale programs efficiently. The latter offers advanced tools for in-store and digital trade-ins, returns processing, inventory management, resale site building, and analytics, serving prominent brands like Canada Goose, Carhartt, and Patagonia. Trove's resale platform aims to drive sustainability in retail by promoting a circular economy.

SKIMS is a brand focused on creating innovative underwear, loungewear, and shapewear designed to enhance body shape. The company manufactures and retails a diverse array of products, including bodysuits, shapewear, and various styles of underwear. SKIMS offers a broad selection of colors and sizes to cater to different body types, ensuring that women receive both the support and coverage they need. By prioritizing inclusivity and functionality, SKIMS aims to address the diverse needs of its customers in the intimate apparel market.

MUSINSA is a fashion business company that offers personalized curation and storytelling for various brands and products. Its platform helps brands and consumers' lifestyles by designing, creating, enjoying, and interacting with fashion. It also delivers fashion trends and information to help customers engage and interact.

Orennia specializes in providing commercial analytics and insights tailored for the renewable and zero-carbon energy sectors. By leveraging advanced technology, the company aggregates and cleanses extensive data related to commercial, engineering, pricing, transmission facilities, and demand. This comprehensive approach allows Orennia to deliver objective insights, empowering investors to make informed capital allocation decisions. With expertise from seasoned industry professionals, Orennia aims to accelerate the investment process in renewable energy, enabling clients to navigate this significant market opportunity with confidence.

Caraway is a digital healthcare company for college women+ that provides integrated mental, reproductive and physical healthcare services. Built with students for students, Caraway arms women+ with the first personalized, equitable and digitally-accessible care solution that prioritizes their needs and concerns. With an unprecedented need for mental health resources and new barriers and persistent inequities in women’s+ health, Caraway provides access to trusted, holistic, and compassionate healthcare so women+ can get the care they need when they need it.

Upstream Bio is a clinical-stage biotechnology company dedicated to developing antibody therapies for inflammatory diseases, particularly severe asthma and other respiratory disorders. The company's lead candidate, verekitug, is a monoclonal antibody that acts as an antagonist to the Thymic Stromal Lymphopoietin (TSLP) receptor. TSLP is a key cytokine that drives inflammatory responses and is strategically positioned upstream of various signaling pathways influencing immune cells. Upstream Bio aims to address unmet medical needs in the treatment of severe respiratory conditions by leveraging this validated target to create effective therapies.

Alkeus Pharmaceuticals is a Boston-based clinical-stage biopharmaceutical company dedicated to developing treatments for serious and untreatable ophthalmic conditions. The company's primary focus is on its lead drug candidate, an orally delivered compound aimed at addressing Stargardt disease and age-related macular degeneration. This innovative treatment has the potential to help medical professionals manage symptoms of irreversible vision loss early in life, offering hope to patients affected by these debilitating eye diseases.

EVgo Services LLC, established in 2010 and headquartered in Los Angeles, specializes in operating a network of fast-charging stations for electric vehicles (EVs) across the United States. The company's infrastructure is compatible with all fast-charge capable EV models, providing up to 90 miles of range in just 30 minutes. EVgo partners with various businesses and organizations, such as grocery stores, automotive manufacturers, and local governments, to strategically place its charging stations, ensuring convenience and accessibility for EV drivers.

Boundless Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of aggressive cancers linked to extrachromosomal DNA (ecDNA). Founded in 2018 and based in La Jolla, California, the company aims to address the significant unmet medical needs of patients with oncogene amplified tumors, which affect over 14% of cancer patients. By targeting ecDNA, a key factor in oncogene amplification, Boundless Bio seeks to provide transformative treatments for previously difficult-to-treat cancers. One of its leading candidates, BBI-355, is an oral, selective inhibitor of checkpoint kinase 1 (CHK1), designed to manage the replication and transcription of ecDNA in cancer cells.

Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Clerkie is an AI-driven financial planning platform designed to assist Americans in managing their debt and enhancing their financial literacy. The company utilizes a proprietary financial automation system that incorporates conversational AI to create detailed financial knowledge graphs. This technology allows users to easily understand their financial situations and take actionable steps toward debt management. By combining expert financial advice with automated solutions, Clerkie aims to simplify the process of addressing debt burdens, making it more accessible for individuals to implement effective financial strategies.

Saluda Medical, established in 2010, is a global medical device company specializing in neuromodulation technologies. Headquartered in Australia with offices in the US and UK, the company develops and commercializes innovative, closed-loop spinal cord stimulation systems. These systems measure and adapt to the spinal cord's response to stimulation, optimizing therapy within each patient's unique therapeutic window. Saluda's primary focus is treating chronic neuropathic pain, with its devices designed to automatically adjust electrical stimulation based on real-time neurophysiological feedback, tailoring treatment to individual patient needs.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

Span.IO designs and develops innovative residential energy storage solutions aimed at facilitating the adoption of renewable energy. The company's flagship product includes a smart electrical panel that replaces traditional panels, providing an intuitive interface for managing home energy use. This system allows users to monitor and control energy consumption remotely through a dedicated application, enhancing the overall consumer experience. Span.IO's team, composed of experts in energy, software, hardware, and consumer finance, leverages their collective knowledge in power generation and system integration to create products that promote environmental sustainability and energy efficiency. Through its technology, Span.IO aims to transform the energy sector by making home energy management more accessible and automated.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Cargo Therapeutics is a clinical-stage biotechnology company focused on developing next-generation CAR T-cell therapies aimed at overcoming cancer treatment resistance and improving patient access to potentially curative options. The company aims to enhance treatment outcomes by addressing the limitations of existing therapies, which currently provide curative benefits to less than half of cancer patients. Its lead program, CRG-022, is a novel CAR T-cell product candidate that targets CD22, a tumor antigen prevalent in many B-cell malignancies. By tackling issues such as limited durability, safety concerns, and supply chain obstacles, Cargo Therapeutics is committed to advancing innovative solutions that make effective cancer treatments more accessible to patients.

Dataiku Inc. is a company that develops a centralized data platform designed to support businesses in their data journey from analytics to enterprise AI. Founded in 2013, and headquartered in New York with additional offices in Paris and London, Dataiku offers a collaborative data science software platform known as Dataiku DSS. This platform enables teams of data scientists, analysts, and engineers to prepare, analyze, and visualize data effectively. It includes tools for data profiling, interactive exploration, and machine learning capabilities, allowing organizations to build and deploy data products efficiently. By providing a repository of best practices and a controlled environment, Dataiku aims to foster collaboration among data professionals and streamline the development of impactful models and innovative solutions. Prominent clients like Unilever and GE utilize Dataiku to enhance their data-driven decision-making processes and adapt to the growing volume of data they manage.

Apogee Therapeutics is a biotechnology company based in San Francisco, California, founded in 2022. The company focuses on developing differentiated biologics for the treatment of immunological and inflammatory disorders, specifically targeting atopic dermatitis and chronic obstructive pulmonary disease. Apogee Therapeutics aims to address high unmet medical needs by advancing novel therapies that utilize advanced antibody engineering to enhance therapeutic properties such as half-life. The company's key programs, APG777 and APG808, are designed to leverage established mechanisms of action to improve treatment outcomes for patients suffering from these conditions.

Rokt is a software development company that specializes in e-commerce technology aimed at enhancing the consumer purchasing experience. By integrating marketing directly into the transaction moment, Rokt connects advertisers to customers, allowing for the placement of native advertisements within the transactional flows of e-commerce sites. This strategic positioning occurs at a time when consumers are most receptive to marketing messages, enabling e-commerce operators to increase revenue while providing a more effective customer experience. Rokt's solutions not only facilitate greater social engagement but also promote higher cross-selling opportunities for brands, thereby transforming the landscape of online shopping.

MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.

Zenas BioPharma is a clinical-stage biopharmaceutical company based in Florida, dedicated to developing immune-based therapies for patients. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody that targets both CD19 and FcγRIIb, which are found on B cells. This innovative approach aims to inhibit the activity of B cells involved in various autoimmune diseases while preserving their overall population, thus offering a potential therapeutic advantage over traditional treatments that deplete these cells.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. It specializes in developing tumor-targeted small molecule medicines that utilize the therapeutic potential of radioisotopes, particularly Actinium-225, an alpha-emitting radioisotope aimed at treating solid tumors. RayzeBio is focused on enhancing cancer treatment outcomes by creating a robust pipeline of radiopharmaceutical candidates targeting validated oncology drug targets. The company's portfolio includes a range of drug candidates at various stages of development, from discovery to late-stage clinical programs, addressing significant market opportunities in the field of cancer therapeutics.

Flavrs is a San Francisco-based shoppable video platform that merges premium food content with commerce, catering to food enthusiasts. Founded in 2020, the platform offers a variety of recipes, ranging from seafood to Thai cuisine, and features video tutorials created in collaboration with renowned chefs and food creators. Users can engage with these tutorials to learn how to reproduce the showcased meals at home. Flavrs enhances the cooking experience by providing a seamless shopping component, allowing users to purchase the necessary ingredients directly through a custom integration with Instacart. This innovative approach enables foodies to discover, replicate, and enjoy a diverse array of culinary creations.

SeatGeek, Inc. is a mobile ticketing marketplace and ticket search engine that facilitates the buying and selling of tickets for sports, concerts, and theater events. Founded in 2009 and headquartered in New York, the company also maintains offices in the United Kingdom, Israel, the Netherlands, Australia, and Italy. SeatGeek's platform aggregates ticket listings from various sources, presenting users with a comprehensive view of available options. It employs a unique feature called 'Deal Score,' which rates tickets on a scale from 0 to 100, helping consumers identify the best value for their purchases. Additionally, SeatGeek offers an event discovery tool that utilizes user preferences to suggest local events that align with individual tastes. By streamlining the ticketing process and providing detailed information about venues and pricing, SeatGeek aims to enhance the overall experience for fans.

Meati Foods is a Boulder, Colorado-based company specializing in the production and sale of fungi-based meat alternatives. Founded in 2016, the company aims to provide sustainable and nutritious plant-based options that serve as an alternative to traditional meat products. Meati Foods utilizes a proprietary fermentation process to create minimally processed steaks made from natural ingredients, ensuring its offerings are free from common allergens. The company markets its products online, making them accessible to a wide audience seeking vegan food choices that are both healthy and environmentally friendly.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in blockchain technology and fintech, offering clients access to cryptocurrency markets for trading, credit, and clearing. FalconX utilizes data science and machine learning to ensure reliable execution of mid-to-large size trades, smart routing prices across multiple liquidity sources. This approach helps eliminate slippage and hidden fees, making it an attractive option for hedge funds, proprietary trading firms, and other institutional clients seeking efficient and cost-effective trading solutions.

Kinside Inc., founded in 2018 and based in Pasadena, California, operates a dual-sided childcare platform that connects working parents with a network of daycares and preschools across the United States. The application enables parents to find and secure childcare options while offering the ability to pay for care online. Kinside's platform provides a comprehensive range of childcare services, allowing parents to access current openings and explore various options. Additionally, it facilitates employer contributions and tax savings, thereby creating a transparent and affordable solution for working families seeking reliable childcare.

Guild's lifelong learning platform offers classes, programs, and degrees for working adults, with a path for them to move forward in their education and careers. It offers these adults support from start to finish, with their technology platform for discovery, learning, and organizing the experience, and extra support with their tech-enabled student advising model.

Arcadia, Inc. is a technology company based in Washington, D.C., founded in 2014, that focuses on providing access to clean energy solutions. Through its platform, Arc, the company connects subscribers to renewable energy sources such as wind farms and community solar projects. By enabling users to manage their accounts, track energy usage, and participate in clean energy initiatives, Arcadia aims to democratize access to renewable energy and combat the fossil fuel monopoly. The platform aggregates energy data from over 125 utilities, representing more than 80% of U.S. electric utility accounts, thus facilitating a significant shift toward sustainable energy practices. Additionally, Arcadia's community solar program addresses energy injustice while promoting economic growth, contributing over five Terawatt-hours of energy demand from residential and commercial users.

Span.IO designs and develops innovative residential energy storage solutions aimed at facilitating the adoption of renewable energy. The company's flagship product includes a smart electrical panel that replaces traditional panels, providing an intuitive interface for managing home energy use. This system allows users to monitor and control energy consumption remotely through a dedicated application, enhancing the overall consumer experience. Span.IO's team, composed of experts in energy, software, hardware, and consumer finance, leverages their collective knowledge in power generation and system integration to create products that promote environmental sustainability and energy efficiency. Through its technology, Span.IO aims to transform the energy sector by making home energy management more accessible and automated.

Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Somatus, Inc. is a healthcare company focused on providing specialized kidney care services aimed at delaying or preventing the progression of chronic kidney disease. Founded in 2016 and headquartered in McLean, Virginia, Somatus collaborates with health plans, health systems, nephrology, and primary care groups to deliver integrated care for patients with or at risk of kidney disease. Its comprehensive services include home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplant, and conservative care. By utilizing vertically integrated clinical services and technology, Somatus seeks to improve patient outcomes, enhance care coordination, and promote the use of home dialysis modalities while increasing the rates of kidney transplantation. The company's mission is to ensure that patients can access the care they need to manage kidney disease effectively.

Synthego Corporation is a genome engineering company focused on advancing life science research and therapeutic development to improve human health. Founded in 2012 and headquartered in Redwood City, California, Synthego offers a comprehensive platform that integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology. The company's product portfolio includes engineered cells, CRISPR kits, and bioinformatics tools designed for various applications such as pathway analysis, target validation, disease modeling, and diagnostics. By leveraging machine learning and automation, Synthego enables researchers in biotechnology and academia to conduct efficient and precise gene editing, facilitating rapid advancements in drug discovery and development. The company serves a global customer base, distributing its products through various channels, including online sales and partnerships in multiple countries.

Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

CodeSee is a company based in San Francisco, California, that specializes in cloud-based data visualization software aimed at enhancing code comprehension. Founded in 2019, CodeSee's platform provides developers and development teams with tools to continuously grasp their codebase throughout the development process. By mapping the relationships between code and functionality, the software facilitates better understanding and management of complex code structures, ultimately aiding in more efficient software development.

Go Digit General Insurance Limited is a Bengaluru-based insurance provider that utilizes a digital platform to offer a wide range of insurance products. Founded in 2016 and formerly known as Oben General Insurance Limited, the company provides services including car, travel, home, commercial vehicle, shop, bike, health, and mobile insurance, as well as group health and flight delay insurance. Go Digit General Insurance is known for its customer-centric approach, focusing on claims processing, renewals, and garage services. The company generates most of its revenue from motor insurance products, catering primarily to the Indian market. As a subsidiary of Go Digit Infoworks Services Private Limited, it aims to innovate in product design and pricing strategies.

Dave Inc. is a financial services company that operates a mobile application designed to enhance users' financial well-being. Founded in 2015 and based in Los Angeles, California, the app alerts users to potential overdrafts, helps predict expenses, and provides access to up to $250 in overdraft protection. Additionally, it offers features such as credit building and resources for finding side jobs, enabling users to manage their finances more effectively. With a user base exceeding 12 million, Dave aims to provide banking services without hidden fees, acting as a supportive tool for individuals seeking to budget, access funds, and receive financial guidance. The application is available on both the App Store and Google Play.

Taqanal Energy focuses on advancing the transition from fossil fuels and internal combustion engines by offering an Intelligent Energy Storage Management System. This system combines embedded intelligence in batteries with cloud applications to enhance the management of energy assets. The company provides tools and interfaces for battery swapping, charging stations, and renewable energy applications, allowing businesses to improve asset management and operational efficiency. Through its innovative solutions, Taqanal Energy aims to facilitate a more sustainable energy future.

Rokt is a software development company that specializes in e-commerce technology aimed at enhancing the consumer purchasing experience. By integrating marketing directly into the transaction moment, Rokt connects advertisers to customers, allowing for the placement of native advertisements within the transactional flows of e-commerce sites. This strategic positioning occurs at a time when consumers are most receptive to marketing messages, enabling e-commerce operators to increase revenue while providing a more effective customer experience. Rokt's solutions not only facilitate greater social engagement but also promote higher cross-selling opportunities for brands, thereby transforming the landscape of online shopping.

Anchorage Digital is a regulated cryptocurrency platform that offers integrated financial services and infrastructure solutions tailored for institutions. Established in 2017 and headquartered in San Francisco, California, the company operates as the only federally chartered crypto bank in the United States, with an additional office in Singapore that maintains similar security and service standards. Anchorage Digital specializes in secure custody, regulatory compliance, and a variety of cryptocurrency-related services, including trading, staking, and governance. The platform emphasizes modern security engineering to ensure the safety of digital assets while facilitating streamlined participation in blockchain technology for businesses and institutions. With a valuation exceeding $3 billion, Anchorage Digital has attracted investments from prominent firms such as Andreessen Horowitz, Goldman Sachs, and Visa, among others. The company also supports a remote-friendly work environment, with additional offices located in New York, Porto, and Sioux Falls.

Juspay is a developer of an online platform designed to be used for mobile-based payments. The company's online platform is a SaaS layer on top of payment gateways to simplify integration, improve robustness and ease the management of diverse and rapidly evolving payment options, enabling users to make electronic transactions securely and efficiently.

Olist is a Brazilian company headquartered in Curitiba that operates an online e-commerce platform designed to facilitate sales for small and medium-sized businesses (SMBs). It acts as a commerce enabler by connecting entrepreneurs to major online marketplaces, allowing them to advertise and sell their products seamlessly. Olist's offerings include Olist Store, which helps merchants sell on various marketplaces, and Olist Shops, a mobile-first e-commerce solution integrated with social media and accessible in 180 countries. Additionally, Olist provides logistics services through Olist Pax, a cloud-based network that supports fulfillment in Brazil, and financial services through Olist Credit and Olist Pay, assisting SMBs with their capital needs. As a leading commerce enabler, Olist is expanding its reach beyond Brazil to serve the global market.

Course Hero operates as an online learning platform dedicated to providing study resources for students and educators. Founded in 2006 and based in Redwood City, California, the company offers a range of materials including lecture notes, study guides, textbook help, practice problems, exams, and video lectures from universities across the United States and internationally. Course Hero's platform is subscription-based and includes an educator platform for distributing materials and publishing content. Additionally, it features a flashcards application and access to expert tutors who assist students with their queries. The company was previously known as TheCollegeFreeway.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Faire is an online wholesale marketplace that connects retailers with unique merchandise from various brands and makers, facilitating a streamlined purchasing process. The platform provides retailers with tools and insights to manage inventory effectively, employing artificial intelligence and predictive analytics to forecast product demand. Faire's offerings include net 60 payment terms and free returns, which reduce the risks associated with wholesale purchasing, enabling local retailers and independent brands to compete with larger e-commerce entities. Headquartered in San Francisco and Kitchener, Faire aims to support the future of local retail by simplifying logistics and enhancing access to diverse products.